Lessee, Operating Lease, Liability, Undiscounted Excess Amount of Sage Therapeutics, Inc. from 30 Sep 2024 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Sage Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 30 Sep 2024 to 31 Dec 2024.
  • Sage Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Dec 2024 was $3,578,000.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

Sage Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $3,578,000 31 Dec 2024 10-K 11 Feb 2025 2024 FY
Q3 2024 $3,847,000 30 Sep 2024 10-Q 29 Oct 2024 2024 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.